{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:19:44Z","timestamp":1785395984241,"version":"3.56.0"},"reference-count":22,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,11,27]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Aminobisphosphonates are recommended for postmenopausal osteoporosis but have been associated with injury to the upper gastrointestinal tract.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To conduct a randomized controlled trial, to assess the endoscopic damage caused by alendronate and its effect on gastric mucosal prostaglandin synthesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Seventy\u2010six healthy volunteers age 40\u201360\u2003years, with normal baseline endoscopy were randomly assigned to treatment with: (A) ASA 650\u2003mg q.d.s.; (B) alendronate 10\u2003mg o.d.; or (C) placebo o.d. for 14\u2003days. Mucosal injury scores on day 14 of treatment were reported by a blinded endoscopist. Gastric biopsies were analysed for prostaglandin E<jats:sub>2<\/jats:sub> (PGE<jats:sub>2<\/jats:sub>) concentration by radioimmunoassay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Oesophageal injury did not differ among treatment groups. Gastric ulcers developed in five out of 26 subjects given ASA, two out of 25 given alendronate, and none of 25 given placebo. The mucosal damage scores for the alendronate group exceeded those for the placebo group in the gastric body but not at other sites. Injury scores for ASA exceeded those for placebo in the duodenum, antrum, body, and fundus. The mean change in log<jats:sub>10<\/jats:sub>[PGE<jats:sub>2<\/jats:sub>] (ng\/mg protein) was \u2212\u20030.07 for placebo, \u2212\u20030.80 for ASA, and +\u20030.62 for alendronate (differences not significant).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Alendronate is associated with injury and ulceration of the gastric mucosa. This effect was not associated with any significant change in gastric mucosal PGE<jats:sub>2<\/jats:sub> levels.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00864.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:11Z","timestamp":1047354011000},"page":"1451-1457","source":"Crossref","is-referenced-by-count":44,"title":["A randomized controlled trial to assess alendronate\u2010associated injury of the upper gastrointestinal tract"],"prefix":"10.1111","volume":"14","author":[{"given":"J. K.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D.","family":"Rainsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(99)80022-8"},{"key":"e_1_2_7_3_2","first-page":"1161","article-title":"United Kingdom experience with alendronate and esophageal reactions","volume":"48","author":"Mackay FJ","year":"1998","journal-title":"Br J Gen Clin Pract"},{"key":"e_1_2_7_4_2","first-page":"1377","article-title":"Clinic visits and hospital admissions for care of acid\u2010related upper gastrointestinal disorders in women using alendronate for esophagitis","volume":"4","author":"Ettinger B","year":"1998","journal-title":"Am J Manag Care"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7117.1235a"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351403"},{"key":"e_1_2_7_7_2","first-page":"1322","article-title":"Primary aminobisphosphonates: a new class of gastrotoxic drugs: a comparison of alendronate and aspirin","volume":"92","author":"Graham DY","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00488.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(99)80007-1"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)01040-0"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018894827961"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00658.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01540567"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00431.x"},{"key":"e_1_2_7_15_2","first-page":"947","article-title":"Protein measurement with the folin phenol reagent","volume":"20","author":"Lowry OH","year":"1951","journal-title":"J Biol Chem"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.219_a.x"},{"key":"e_1_2_7_17_2","first-page":"A237","article-title":"Effect of bisphosphonates on the surface hydrophobicity and phosphatidylcholine concentration of gastric mucosa","volume":"116","author":"Lichtenberger LM","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-8-636"},{"key":"e_1_2_7_19_2","unstructured":"LoweCE DepewWT PatersonWG et\u2003al.Upper gastrointestinal toxicity of alendronate.Am J Gastroenterol2000:63440."},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.517"},{"key":"e_1_2_7_21_2","first-page":"1916","article-title":"The effects of aminoversus alkyl\u2010bisphosphonates on the healing of aspirin\u2010induced stomach erosions","volume":"91","author":"Lanza FL","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_22_2","first-page":"2609","article-title":"Alendronate and naproxen are synergistic in producing gastric ulcers","volume":"94","author":"Graham DY","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199814050-00007"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00864.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00864.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00864.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:02:45Z","timestamp":1698566565000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00864.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,27]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11,27]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00864.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00864.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,27]]}}}